Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV
HIV Medicine · 2024
DOI: 10.1111/hiv.13617 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIV Medicine, 2024. Verfasst von Luis Ramos-Ruperto und 13 weiteren Autor:innen. Beteiligte Einrichtung: HIV Unit, Internal Medicine Department, La Paz-Carlos III University Hospital, IdiPaz, Madrid, Spain. Hauptthemen laut MEDLINE: Rilpivirine, Pyridones, Heterocyclic Compounds, 3-Ring, Oxazines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Introduction
Dolutegravir + rilpivirine (DTG + RPV) is an effective antiretroviral therapy regimen approved in clinical guidelines as a switch therapy for virologically suppressed people with HIV. Our study aimed to compare the effectiveness and tolerability of DTG + RPV in women and men in real‐world clinical practice.
Methods
This was a retrospective analysis of treatment‐experienced people with HIV from a large HIV unit who switched to DTG + RPV. We analysed treatment effectiveness, rates of adverse events and discontinuation, and metabolic changes after 48 weeks of treatment. HIV‐RNA levels
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HIV Unit, Internal Medicine Department, La Paz-Carlos III University Hospital, IdiPaz, Madrid, Spain.
- CIBER de Enfermedades Infecciosas CIBER INFECC, Instituto de Salud Carlos III, Madrid, Spain.
ORCID-Profile: Luis Ramos-Ruperto, Maria Del Mar Arcos-Rueda, María Luisa Montes
Zitieren
APA
Ramos-Ruperto, L., Arcos-Rueda, M. D. M., de Miguel-Buckley, R., Busca-Arenzana, C., Mican, R., Montejano, R., Delgado-Hierro, A., Montes, M. L., Valencia, M. E., Serrano, L., Arribas, J. R., González, J., Bernardino, J. I., & Martín-Carbonero, L. (2024). Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV. HIV Medicine. https://doi.org/10.1111/hiv.13617
Vancouver
Ramos-Ruperto L, Arcos-Rueda MDM, de Miguel-Buckley R, Busca-Arenzana C, Mican R, Montejano R, et al. Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV. HIV Medicine. 2024. doi:10.1111/hiv.13617
BibTeX
@article{RamosRuperto2024,
author = {Ramos-Ruperto, Luis and Arcos-Rueda, Maria Del Mar and de Miguel-Buckley, Rosa and Busca-Arenzana, Carmen and Mican, Rafael and Montejano, Rocío and Delgado-Hierro, Ana and Montes, María Luisa and Valencia, María Eulalia and Serrano, Lucía and Arribas, José Ramon and González, Juan and Bernardino, Jose Ignacio and Martín-Carbonero, Luz},
title = {Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV},
journal = {HIV Medicine},
year = {2024},
doi = {10.1111/hiv.13617}
}
EUVIMED